# Tomasz Poninski

> Tomasz Poninski is a Series A investor at Montis Capital Group backing Biotechnology and AgTech. See 3 investments, check sizes, portfolio. Updated Aug 2026.

- Type: Angel Investor
- Fund: [Montis Capital Group](https://shizune.co/investors/profile/montis-capital-group)
- Location: Warsaw, Poland
- Total investments: 3
- Last investment: Dec 2022
- Lead investor: 0%
- Last updated: Aug 2026
- LinkedIn: https://pl.linkedin.com/in/tomasz-poninski-3b1286

Tomasz Poninski is a Series A investor at Montis Capital Group in Warsaw focused on Biotechnology and AgTech. Tomasz Poninski

## Investment focus

### Industry

| Industry | Investments | Share |
| --- | --- | --- |
| Biotechnology | 2 | 67% |
| AgTech | 1 | 33% |
| Agriculture | 1 | 33% |
| Internet of Things | 1 | 33% |

## Investments

| Company | Description | Amount | Stage | Date | Website |
| --- | --- | --- | --- | --- | --- |
| Fresh Inset | Fresh Inset Vision is to save the fresh produce resources by delivering efficient and seamless Vidre+ technology to preserve product freshness throughout the supply chain from packer/shipper to end user | $2.3M | Series A | Dec 13, 2022 |  |
| Talkin' Things | Talkin Things is a EU based IoT one-stop-shop for bringing off-line products online. We are innovator and technology leader in solutions that change the shape of the industry and help clients to access and use data about their physical products or assets that radically increase efficiency of their processes.Trillions of products and items aremissing the benefits 
of automated data capture and processing due to high 
item cost of the solutions. And our mission is to bring those offline products online using our RFID ecosystem.We have a strong R&D and hardware team and run state-of-the art RFID manufacturing facility.It is us who was fist to introduced the 3 cent tag (Aug 2020) - a beginning of true revolution in this industry. A fully functional RFID tag enabling all benefits of this technology, now avialable for mass produced goods to bring them online. | $20M | Series A | May 11, 2022 |  |
| Biotts SA | We develop proprietary drug delivery technologies and drug formulas in the field of oncology, dermatology and autoimmune diseases. | $1.5M | Series A | May 22, 2020 |  |

3 of 3 investments shown.

## Co-investors
- [Infini VC](https://shizune.co/investors/profile/infini-vc) — VC Fund, 1 deal together
- [Prosegur](https://shizune.co/investors/profile/prosegur) — VC Fund, 1 deal together
- [Rubicon Partners](https://shizune.co/investors/profile/rubicon-partners-174b) — VC Fund, 1 deal together
- [Synthex Technologies](https://shizune.co/investors/profile/synthex-technologies) — VC Fund, 1 deal together
- [TDJ](https://shizune.co/investors/profile/tdj) — VC Fund, 1 deal together

## About Montis Capital Group

VC Fund · Warsaw, Poland

Montis Capital seeks to work with great teams, scalable business models, innovative and already market validated products on providing for expansion and growth capital within the following two sectors:Industry 4.0:We aim to be at the heart of a Fourth Industrial Revolution by investing into a confluence of robotics, artificial intelligence,internet of things, big data or deep tech.Life Science:We look for projects in fields of biotechnology, pharmaceuticals, biomedical technologies, life systems technologies, nutraceuticals, cosmeceuticals, food processing, environmental and biomedical devices.

5 contacts available at Montis Capital Group.

| Name | Title | Profile |
| --- | --- | --- |
| Wojciech Szwankowski | Managing Partner | https://shizune.co/investors/profile/wojciech-szwankowski |
| Katarzyna Laszczynowska | Head of Legal & Compliance | https://shizune.co/investors/profile/katarzyna-laszczynowska |
| Lukasz Dziekonski | Managing Partner | https://shizune.co/investors/profile/lukasz-dziekonski |
| Michal Gaweda | Investment Manager | https://shizune.co/investors/profile/michal-gaweda |
| Tomasz Poninski | Managing Partner | https://shizune.co/investors/profile/tomasz-poninski |

## Similar investors

### Similar stage
- [Antler](https://shizune.co/investors/profile/antler-be9c) — VC Fund
- [Alumni Ventures](https://shizune.co/investors/profile/alumni-ventures-group) — VC Fund
- [General Catalyst](https://shizune.co/investors/profile/general-catalyst-partners) — VC Fund

## FAQ

### What does Tomasz Poninski invest in?

Tomasz Poninski invests primarily in Biotechnology, AgTech and Agriculture startups, most often at Series A stage. Most of the 3 investments tracked by Shizune back companies in Poland. The Investment Focus section breaks down every industry, stage and country in the portfolio.

### When did Tomasz Poninski last invest?

The most recent investment recorded for Tomasz Poninski closed in Dec 2022. Shizune tracks 3 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.

### Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co